1,381 results on '"Ohe, Y."'
Search Results
252. Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell lung cancer.
253. A phase II trial of zoledronic acid in combination with cisplatin and docetaxel in non-small cell lung cancer patients with bone metastases.
254. Safety and efficacy trial of cisplatin (P) with vinorelbine (V) followed by gefitinib (G) and concurrent thoracic radiotherapy (TRT) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): Japan Clinical Oncology Group (JCOG) 0402.
255. Analysis of disease recurrence in the central nervous system (CNS) in patients with non-small cell lung cancer (NSCLC) after responded to gefitinib.
256. Evaluating the complementarity of the educational function in agriculture
257. OP78 EGFR mutations based on circulating free DNA (cfDNA) in the subset of Japanese patients (pts) from IPASS (IRESSA Pan ASia Study), a Phase III study of first-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in clinically selected patients with advanced non-small-cell lung cancer (NSCLC)
258. Gender Difference in Treatment Outcomes in Patients with Stage III Non-small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
259. A phase I study of enzastaurin (Enz) combined with pemetrexed (Pem) in advanced non-small cell lung cancer (NSCLC)
260. Impact of revised lymph node measurement rules in the new RECIST version 1.1 on the tumor response evaluation in patients with advanced lung cancer
261. Genome-wide association scan detected candidate polymorphisms associated with overall survival (OS) in advanced non-small cell lung cancer (NSCLC) treated with carboplatin (CBDCA) and paclitaxel (PTX)
262. Phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in selected patients (pts) with advanced non-small cell lung cancer (NSCLC) (IPASS): Evaluation of recruits in Japan
263. Phase I study of concurrent high-dose three-dimensional conformal radiotherapy (3D-CRT) without elective nodal irradiation with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small cell lung cancer (NSCLC)
264. The prediction of effect of lumbar epidural anesthesia
265. Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
266. Characteristics and issues of rural tourism in Japan
267. Genetic polymorphisms correlate with overall survival (OS) in advanced non-small cell lung cancer (NSCLC) treated with carboplatin (CBDCA) and paclitaxel (PTX)
268. Differences in the toxicity and efficacy in phase I studies between cytotoxic and molecular-targeted therapies
269. Randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC): Final results
270. Circulating tumor cell analysis in patients with non-small cell lung cancer
271. The Intensity Distribution of Electric Field Radiating from the High Power Pulsed Electromagnetic Wave Generator with Water Gap Switch and Water Capacitor
272. Emerging environmental and educational service of dairy farming in Japan: dilemma or opportunity?
273. M08-01: Taxane-platinum pharmacogenomic predictors of outcome in Japan-USA common arm studies in advanced non-small cell lung cancer (NSCLC): a model for testing population-related pharmacogenomics
274. Effect of Platinum Combined with Irinotecan or Paclitaxel against Large Cell Neuroendocrine Carcinoma of the Lung
275. Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207
276. Use of the UNIBLOCKER-bronchial blocker tube to facilitate one-lung ventilation during video-assisted thoracoscopic surgery
277. Output characteristics of high power pulsed electromagnetic wave generator for medical applications using water capacitor and water gap switch
278. A comparison of two types of new bronchial blockers, Uniblocker™ and Coopdech endotracheal blocker tube, for one-lung ventilation during thoracoscopy
279. Evaluating jointness of multifunctional agriculture: the educational function of dairy farming in Japan
280. Retired baby boomers as operators of sustainable rural tourism: the roles and significance
281. A randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC): Preliminary results
282. A randomized double-blind phase IIa dose-finding study of ZD6474 in Japanese patients with NSCLC
283. Evaluation of epidermal growth factor receptor (EGFR) mutations as predictive and prognostic indicators in patients with adenocarcinoma of the lung treated with conventional chemotherapy
284. Phase II study of weekly cisplatin, etoposide and irinotecan (PE/CPT) for refractory relapsed small cell lung cancer (SCLC)
285. EGFR mutations detected by high-resolution melting analysis (HRMA) as a predictor of response and survival in non-small cell lung cancer (NSCLC) patients treated with gefitinib
286. Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC)
287. The use of small-dose vecronium and midazolam facilitate laryngeal mask airway ProSeal, during target-controlled infusion of propofol
288. A comparison of two types of new broncheal blockers and a single lumen tracheal tube for one-lung ventilation during thoracoscopy
289. Nanosecond High Voltage Pulse Generator using Water Gap Switch for Compact High Power Pulsed Microwave Generator
290. Genetic Variations and Haplotype Structures of theABCB1Gene in a Japanese Population: An Expanded Haplotype Block Covering the Distal Promoter Region, and Associated Ethnic Differences
291. O-190 Genetic, immunohistochemical, and clinical features associated with gefitinib sensitivity in patients with advanced non-small-cell lung cancer
292. Evaluation of epidermal growth factor receptor (EGFR) mutations and gene copy numbers as predictors of clinical outcomes in Japanese patients with recurrent non-small-cell lung cancer (NSCLC) receiving gefitinib
293. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan
294. Dose intensive chemotherapy for limited-stage (LS) small cell lung cancer (SCLC): A phase II study
295. Induction of cytochrome P450 (CYP3A4) by gefitinib in non-small cell lung cancer (NSCLC) patients
296. Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
297. Japan-SWOG common arm analysis of paclitaxel/carboplatin in advanced stage non-small cell lung cancer (NSCLC): A model for prospective comparison of cooperative group trials
298. Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive stage small cell lung cancer (ED-SCLC) (final report)
299. The Four-Arm Cooperative Study (FACS) for advanced non-small-cell lung cancer (NSCLC)
300. Pharmacokinetics and pharmacodynamics of weekly epoetin beta in lung cancer patients with chemotherapy-induced anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.